Moviprep

Ascorbic Acid, the active ingredient in Moviprep, is an osmotic laxative presented as an oral solution for oral use. It is used to cleanse the bowel before colonoscopy or sigmoidoscopy in adult patients.

GNH USA supplies Moviprep as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moviprep, an osmotic laxative used for bowel preparation, is indicated for the following clinical situations:

Colonoscopy: provides thorough bowel cleansing to allow clear visualization of the colon. Sigmoidoscopy: achieves rapid evacuation of the colon for optimal examination. Pre‑procedure bowel cleansing: ensures adequate intestinal emptying before radiologic or surgical procedures.

Moviprep may cause a range of adverse reactions. Patients should be aware of both common and less frequent but serious events.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal discomfort: cramping or pain during evacuation. - Bloating: sensation of abdominal fullness. - Vomiting: occasional expulsion of stomach contents. - Thirst: increased desire for fluids. - Mild electrolyte changes: transient shifts in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Significant electrolyte disturbance: dangerous hyponatremia or hyperkalemia. - Renal impairment: worsening kidney function in susceptible individuals. - Allergic reaction: rash, itching, or swelling. - Severe abdominal pain: persistent or worsening pain. - Colitis: inflammation of the colon.

Before prescribing Moviprep, clinicians should consider several safety aspects.

Renal function: assess kidney function prior to use. Electrolyte balance: monitor serum electrolytes in patients at risk of disturbances. Cardiac disease: use with caution in patients with heart failure or arrhythmias. Pregnancy: avoid unless clearly needed, as safety data are limited. Diabetes: consider potential impact of ascorbic acid on glucose levels. Store at ambient temperature: keep in the original container, protect from moisture and light.

Moviprep can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Diuretics: may exacerbate electrolyte loss. - ACE inhibitors or ARBs: increase risk of renal impairment. - Oral sodium phosphate preparations: combined bowel prep can cause severe electrolyte shifts. - Lithium: dehydration may raise lithium levels. - Anticholinergic agents: may reduce bowel‑cleansing efficacy.

Moderate Interactions (Monitor Closely): - NSAIDs: monitor renal function due to additive nephrotoxic risk. - Antihypertensives: watch blood pressure as fluid shifts may cause hypotension. - Insulin or oral hypoglycemics: monitor blood glucose because of potential changes in fluid and electrolyte status.